The updates to the NHPID listed below apply to the most recent version of the web-based Product Licence Application (web PLA) form. All new product licence application submissions must use the web PLA form.
New Ingredients
In this update, the following non-homeopathic ingredients were added.
NHPID Name: Albatrellus Confluens (Mushroom) Extract
Role: Non-Medicinal
Revised NHPID Names
In this update, the following non-homeopathic ingredients had their NHPID name revised.
Old NHPID Name: 1,3-Butylene glycol
New NHPID Name: 1,3-Butylene Glycol
Old NHPID Name: Fulvic acid
New NHPID Name: Fulvic Acids
Revised Proper and Common Names
In this update, the following non-homeopathic ingredients had their common or proper names revised.
NHPID Name: Fulvic Acids
Removed Proper Name(s): 3,4-Dihydro-3,7,8-trihydroxy-3-methyl-10-oxo-1H,10H-pyrano(4,3-b)
Name(s): (1)benzopyran-9-carboxylic acid
NHPID Name: Fulvic Acids
New Proper Name(s): Fulvic acids
Revised Restrictions
In this update, the following non-homeopathic ingredients underwent a modification related to their restrictions.
NHPID Name: 1,3-Butylene Glycol
Non-medicinal Restriction(s) changed: New Allowed Purposes: Fragrance Ingredient; Skin-Conditioning Agent; Solvent;
Restriction(s) changed: Viscosity Decreasing Agent
Other Ingredient Modifications
In this update, the following non-homeopathic ingredients underwent a modification different from those listed above, such as new source material, new preparation type, or new sub-ingredient relationship, etc.
NHPID Name: 1,3-Butylene Glycol
CAS Registry Number(s) removed: 18826-95-4
NHPID Name: 1,3-Butylene Glycol
New Toxicity restriction added: Upper Limit: 4.0 ; Units: Milligrams/kilogram body weight/day ; Detail: Acceptable daily intake up to 4 mg/kg bw/day. ; Reference: WHO_JECFA
NHPID Name: 1,3-Butylene Glycol
New NMI Purpose(s): Fragrance Ingredient; Viscosity Decreasing Agent
NHPID Name: Fulvic Acids
Modification: Removed Structure: Fulvic acid.gif
NHPID Name: Fulvic Acids
Modification: Revised Schedule 1: Extract
NHPID Name: Fulvic Acids
CAS Registry Number(s) removed: 479-66-3
NHPID Name: Fulvic Acids
New Source Ingredient(s) added: Lignite
NHPID Name: Fulvic Acids
Medicinal Rationale changed: Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.
NHPID Name: Lignite
New Sub-ingredient(s) added: Fulvic Acids
NHPID Name: Vitamin B12
New Source Material(s) added: Auxenochlorella Pyrenoidosa – Broken cell
NHPID Name: Iron
New Source Material(s) added: Auxenochlorella Pyrenoidosa – Broken cell
NHPID Name: Auxenochlorella Pyrenoidosa
Modification: New Source Material Constituent(s): Broken cell
NHPID Name: Auxenochlorella Pyrenoidosa
New Sub-ingredient(s) added: Vitamin B12
All information sourced from Health Canada – Natural Health Products Ingredients Database.
Linda Beach is the founder, sole owner, and Director of Canadian Natural Health Product Registry (CNHPR), operating under Medical Botany Research. Based on Canada’s west coast, Linda has been providing regulatory consulting and compliance expertise to Canadian and international companies since 2004, when Canada’s Natural Health Products Regulations first came into effect.
A Certified Herbalist with a degree in Botany and Medical Research, Linda also holds certifications in several natural and complementary healing modalities. This combination of scientific training and hands-on herbal expertise gives her a unique perspective on the products she helps bring to market — from vitamins and herbal remedies to nutraceuticals, cosmeceuticals, and sports supplements.
Over her two decades working directly with Health Canada, Linda has built strong working relationships with regulators that have translated into consistent success in securing Natural Product Numbers (NPNs) for her clients. Her advocacy work has had industry-wide impact — including playing a key role in Health Canada’s decision to reinstate hempseed oil to its approved ingredient database after it had been removed, restoring a path to market for products containing the ingredient.
Through CNHPR, Linda guides clients through every stage of the licensing process: developing a tailored regulatory strategy, compiling required documentation, and managing submissions from signing through to Health Canada approval.
